SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Purchased by Howard Capital Management Group LLC

Howard Capital Management Group LLC lifted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.4% in the fourth quarter, HoldingsChannel reports. The firm owned 254,166 shares of the exchange traded fund’s stock after buying an additional 6,052 shares during the period. SPDR S&P Biotech ETF makes up about 1.6% of Howard Capital Management Group LLC’s portfolio, making the stock its 28th biggest holding. Howard Capital Management Group LLC’s holdings in SPDR S&P Biotech ETF were worth $22,890,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in shares of SPDR S&P Biotech ETF by 198.6% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after buying an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd purchased a new position in SPDR S&P Biotech ETF in the third quarter worth approximately $141,284,000. Northwestern Mutual Wealth Management Co. increased its stake in SPDR S&P Biotech ETF by 1.6% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock worth $106,158,000 after acquiring an additional 18,202 shares during the last quarter. Mirae Asset Securities USA Inc. raised its position in SPDR S&P Biotech ETF by 50.0% in the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after purchasing an additional 300,000 shares during the period. Finally, Employees Retirement System of Texas lifted its stake in shares of SPDR S&P Biotech ETF by 40.8% in the 2nd quarter. Employees Retirement System of Texas now owns 603,857 shares of the exchange traded fund’s stock valued at $55,984,000 after purchasing an additional 174,857 shares during the last quarter.

SPDR S&P Biotech ETF Trading Up 2.9 %

Shares of NYSEARCA:XBI opened at $90.51 on Wednesday. The company has a market capitalization of $6.90 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47. The business has a 50-day moving average price of $93.58 and a 200 day moving average price of $96.95.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.